TITLE
Metabolic re-programming of pancreatic cancer mediated by CDK4/6 inhibition elicits unique vulnerabilities

ORGANISM
Homo sapiens

SUMMARY
Gene expression levels were determined with control or PD-0332991 treatment

DESIGN
CAPAN2 Cells were subject to DMSO/ PD-0332991 treatment.   RNA was harvested at 72 hours post treatment and analyzed on Illumina microarrays

